EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,910 | +213.0% | 73,525 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $7,000 | -36.4% | 73,525 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -26.7% | 73,525 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | -67.4% | 73,525 | -5.0% | 0.00% | -66.7% |
| Q4 2021 | $46,000 | -4.2% | 77,425 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $48,000 | -39.2% | 77,425 | -7.1% | 0.00% | -25.0% |
| Q2 2021 | $79,000 | – | 83,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |